We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
DNAnexus and Sutter Health have partnered with the University of Pittsburgh Medical Center (UPMC) to launch a clinico-genomic study aimed at improving personalised therapy for multiple sclerosis (MS) patients.